PEDMARQSI 80 mg/ml sol perf 80 mg 1 pce

7680701940015 CH-70194 V03AB06 15.01.0.

No images available

Details

Product number
7019401
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
natrii thiosulfas anhydricus 80 mg, acidum boricum 0.25 mg, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 23.27 mg.

Articles (1)

Pedmarqsi 80 mg/ml, Infusionslösung
Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2026
Patient information leaflet
Français
01/05/2026
Patient information leaflet
Italien
01/05/2026
Professional SmPC
Allemand
01/05/2026
Professional SmPC
Français
01/05/2026
Professional SmPC
Italien
01/05/2026

Detailed composition

Substance Quantity Type Category
natrii thiosulfas anhydricus
80.0 MG Substance Wirkstoff (Principe actif)
acidum boricum
0.25 MG Substance HBESI
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
23.27 MG Substance HBESI

Authorization holder

Norgine AG

6005 Luzern

Authorization information

Swissmedic authorization number
70194
Drug name
Pedmarqsi, Infusionslösung
Galenic form
LSINF
ATC Code
V03AB06
Authorization status
Z
Dispensation category
A
First authorization
18/03/2026
Authorization expiration date
17/03/2031
IT number
15.01.0.
Domain
Human medicine
Field of application
Vorbeugung einer durch Cisplatin verursachten Ototoxizität bei Kindern im Alter von 1 Monat bis < 18 Jahren

Packaging details

Description (FR)
PEDMARQSI 80 mg/ml sol perf 80 mg 1 pce
Description (DE)
PEDMARQSI 80 mg/ml Inf Lös 80 mg 1 Stk
Market launch
01/05/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data